• SPX
  • $5,762.48
  • 0.42 %
  • $24.31
  • DJI
  • $42,330.15
  • 0.04 %
  • $17.15
  • N225
  • $38,637.75
  • 1.89 %
  • $718.27
  • FTSE
  • $8,236.95
  • -1.01 %
  • -$83.81
  • IXIC
  • $18,189.17
  • 0.38 %
  • $69.58
ShockWave Medical, Inc. (SWAV) Stock Price, News & Analysis

ShockWave Medical, Inc. (SWAV) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$334.75
Day's range
$334.9
50-day range
$276.79
Day's range
$334.9
  • Country: US
  • ISIN: US82489T1043
52 wk range
$157
Day's range
$334.9
  • CEO: Mr. Douglas E. Godshall M.B.A.
  • Website: Visit Site
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 10.29
  • Piotroski Score 6.00
  • Grade Market Perform
  • Symbol (SWAV)
  • Company ShockWave Medical, Inc.
  • Price $334.75
  • Changes Percentage (-0.02%)
  • Change -$0.08
  • Day Low $334.75
  • Day High $334.90
  • Year High $334.90

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 08/05/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $239.50
  • High Stock Price Target $360.00
  • Low Stock Price Target $175.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Buy
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $4.25
  • Trailing P/E Ratio 78.76
  • Forward P/E Ratio 78.76
  • P/E Growth 78.76
  • Net Income $147.28 M

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.